TCT-239 Impact of Post-stenting Balloon Dilatation on 5-year Clinical Outcomes in Patients with Acute Coronary Syndrome underwent Percutaneous Coronary Intervention

Impact of Post Stent Deployment Balloon Dilatation During Primary Percutaneous Coronary Intervention on Long-Term Outcomes

“…(14) Abdelshafi et al, 2018, during their follow up study reported the incidence of stroke among patients underwent PSBD as 14 % while it was 17.6% among non-PSBD patients, which was statistically significant. (3) In the current study, stroke incidence did not show any statistical significant difference between both studied groups.…”

“…It was reported that adjunctive PSBD with non-compliant balloons can increase MSA and decrease the frequency of suboptimal stent deployment and potentially reduce the frequency of stent thrombosis and TVR. (3) Many interventionalists have considered that adjunctive PSBD may not be necessary with DES deployment. However, TVR still occurs in 7-9% of patients following DES implantation, and stent thrombosis remains a major concern.…”

“…This result was consistent with the result of Abdeshafi et al 2018, who reported TVR as 5.4% among patients with PSBD compared with 7.4% for those with no PSBD. (3) On the contrary, Gao P. et al 2018, found that TVR was 5.6% among PSBD patients compared with 0.8% in no PSBD patients with STEMI during follow up from 1-12 months. (14) Abdelshafi et al, 2018, during their follow up study reported the incidence of stroke among patients underwent PSBD as 14 % while it was 17.6% among non-PSBD patients, which was statistically significant.…”

“…There are limited data regarding the impact of post-stenting balloon dilatation on long term clinical outcomes in ACS patients. (3) There have been some concerns about the risks of adjunctive balloon post-dilatation, particularly in the setting of acute coronary syndrome (ACS). Therefore, PSBD remains at operators' discretion in clinical practice as well as in large interventional trials.…”